Vitamin B12 1200 mcg Extended Release Tablet
Natural health product licensed in Canada
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Vitamine B12 Source : Cyanocobalamine | 1,200 mcg | Not calculated |
Non-medicinal ingredients
Dioxyde de titane, Talc, Phosphate dicalcique, Stéarate de magnésium, Dioxyde de silicium, Rouge allura AC, Laque d'aluminium - carmin d'indigo, Poly(éthylène glycol), Hypromellose, Poly(alcool vinylique), Cire de Carnauba
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1 Comprimé | 1 Tous les jours |
Uses authorised in Canada
A factor in the maintenance of good health. Contributes to maintaining general health. For maintaining general health. Helps in energy metabolism in the body. Helps in the normal function of the immune system. Helps to form red blood cells. Helps to maintain healthy metabolism. Helps to maintain the body's ability to metabolize nutrients. Helps to prevent vitamin B12 deficiency. Helps to prevent vitamin B12 deficiency and to form red blood cells. Maintains good health. Supports good health. Vitamin supplement.Source of vitamin B12, a factor in normal growth and development. Source of vitamin B12, a factor in the maintenance of good health. Source of vitamin B12 to support biological functions which play a key role in the maintenance of good health.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Product record
- Licence holder
- Wampole Group L.P.
- NPN or DIN-HM
- 80105487
- Status
- Active licence
- Licence date
- 20 October 2020
- Revision date
- Not provided
- Form
- Comprimé, enrobé par pellicule, libération prolongée
- Route of administration
- Orale
- Application type
- Générale (non traditionelle)
Source
Official Health Canada record, licence 80105487
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “Vitamin B12 1200 mcg Extended Release Tablet”, https://compoatlas.com/en/supplements/canada/80105487-vitamin-b12-1200-mcg-extended-release-tablet, updated 20 October 2020.